Focused Photonics Inc’s (SHE: 300203) subsidiary Expeclinlab has secured RMB 185 million (USD 27.7 million) in its latest funding round. The investment was led by Sequoia Capital China, Shandong Huiyuan Technology Development Co., Ltd, and four other investors, with proceeds earmarked to accelerate business development.
Expeclinlab’s Specialization and Products
Expeclinlab, a specialist in clinical mass spectrometry, focuses on mass spectrometry hardware, personalized customization, in vitro diagnostic kits for clinical medical samples, application technology, and clinical research collaboration. The company highlights its in-house developed PreMed 5200 liquid chromatography tandem mass spectrometry detection system and PreMed 7000 trace element analyzer, both of which have obtained market approvals in China.-Fineline Info & Tech
